Company profile
AbbVie Inc.
NYSE: ABBV · Healthcare · Drug Manufacturers - General
#14 of 1,418 Healthcare companies by revenue54th-percentile growth
EA Score
81B+FH 88DQ 79GM 61SS 86
v0.1 · 65/100 weight · provisional
↑ market scale, workforce scale · ↓ 3-yr revenue growth, revenue growth (YoY)
Methodology →Revenue TTM
$62.8B
Rev growth YoY (TTM)
+9.5%
Net income (FY)
$4.2B
Employees
57,000
as of 2026-08-04
Market cap
$433.0B
as of 2026-08-04
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$61.2B$61.2B2025
Net income$4.2B$4.2B2025
Operating income$15.1B$15.1B2025
Total assets$134.0B$134.0B2025
Equity-$3.3B-$3.3B2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
SKYRIZI30%
RINVOQ14%
H U M I R A8%
Botox Therapeutic6%
Vraylar6%
Imbruvica5%
By geography
UNITED STATES95%
Non-US5%
The read
What is AbbVie Inc.’s revenue?
AbbVie Inc. booked $61.2B in FY2025 revenue, growing 8.6% year over year — about the middle of the pack among Healthcare companies we track, at a 6.9% net margin.
Peers · Healthcare
Eli Lilly and Company93AMerck & Co., Inc.84B+Pfizer Inc.76B+Bristol-Myers Squibb Company85AMolina Healthcare, Inc.83B+Thermo Fisher Scientific Inc.86ANeighbors
Lake →Key facts
CEORobert A. Michael
SectorHealthcare
IndustryDrug Manufacturers - General
HeadquartersNorth Chicago, IL
ExchangeNYSE: ABBV
Employees57,000
IPO date2013-01-02
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.